Paushak Limited Reports Q3FY26 Results with Revenue Growth of 3.1% YoY
Paushak Limited reported Q3FY26 results with revenue from operations of ₹4,880 lacs, down 0.9% from Q3FY25. Net profit declined significantly by 59.6% to ₹617 lacs. For nine months, revenue grew 3.1% to ₹16,346 lacs while profit decreased 32.6% to ₹2,682 lacs. The company completed major corporate actions including bonus share issuance and NSE listing during the period.
*this image is generated using AI for illustrative purposes only.
Paushak Limited has announced its unaudited financial results for the third quarter of FY26 ended December 31, 2025, showing mixed performance with revenue growth but declining profitability. The Gujarat-based specialty chemicals company's Board of Directors approved the results at a meeting held on January 27, 2026.
Financial Performance Overview
The company's quarterly performance presents a contrasting picture of top-line growth and bottom-line pressure:
| Metric | Q3FY26 | Q3FY25 | Change (%) |
|---|---|---|---|
| Revenue from Operations | ₹4,880 lacs | ₹4,926 lacs | -0.9% |
| Total Income | ₹4,977 lacs | ₹5,557 lacs | -10.4% |
| Net Profit | ₹617 lacs | ₹1,526 lacs | -59.6% |
| Earnings per Share | ₹2.50 | ₹6.19 | -59.6% |
Nine-Month Performance Analysis
For the nine-month period ended December 31, 2025, Paushak demonstrated resilience in revenue generation while facing profitability challenges:
| Parameter | 9M FY26 | 9M FY25 | Growth (%) |
|---|---|---|---|
| Revenue from Operations | ₹16,346 lacs | ₹15,859 lacs | +3.1% |
| Total Income | ₹16,736 lacs | ₹17,272 lacs | -3.1% |
| Net Profit | ₹2,682 lacs | ₹3,977 lacs | -32.6% |
| Earnings per Share | ₹10.88 | ₹16.13 | -32.5% |
Cost Structure and Operational Metrics
The company's expense analysis reveals several key trends affecting profitability. Employee benefits expense increased to ₹1,090 lacs in Q3FY26 from ₹932 lacs in Q3FY25, partly due to additional provisions of ₹101.07 lacs related to new Labour Codes implemented by the Government of India on November 21, 2025. Cost of materials consumed rose to ₹1,198 lacs from ₹976 lacs in the corresponding quarter last year.
Corporate Actions and Structural Changes
Paushak undertook significant corporate restructuring during the period. The company's authorized share capital was reclassified to ₹20 crore divided into 4 crore equity shares of ₹5 each. A major bonus issue was executed with 1,84,92,684 equity shares allotted in a 3:1 ratio on October 6, 2025. The paid-up equity share capital increased substantially to ₹1,233 lacs from ₹308 lacs in the previous year.
Market Expansion and Listing
The company achieved a significant milestone with its equity shares getting listed on the National Stock Exchange of India Limited effective December 1, 2025. This dual listing on both BSE and NSE enhances the company's market accessibility and liquidity for investors. The Board of Directors had approved the NSE listing proposal at their meeting held on October 9, 2025.
Regulatory Compliance and Outlook
The financial results were reviewed by statutory auditors CNK & Associates LLP and approved by the Board of Directors. The company operates exclusively in the specialty chemicals business, maintaining focus on its core competency. The implementation of new Labour Codes represents an ongoing regulatory adaptation that the company is managing through appropriate provisioning mechanisms.
Historical Stock Returns for Paushak
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.63% | -7.49% | -17.68% | -17.41% | -17.41% | -17.41% |
20
